Skip to main content

Advertisement

Table 1 Patient and tumor characteristics

From: Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy

   Survivors Non-survivors NA*
   (n = 60) (n = 23) (n = 2)
Mean age (± SD) years 51.1 ± 10.6 49.3 ± 8.3 46.4 ± 2.6
Mean tumor dimensions (mean ± SD) mm 67.9 × 67.9 ± 18.0 × 19.8 78.6 × 77.3 ± 22.0 × 24.0 65.0 × 51.5 ± 7.1 × 26.2
NAC treatment Epirubicin 25 8 -
  Paclitaxel 23 5 2
  Both1 12 10 -
Treatment Partial response 40 11 1
response Stable disease 20 12 1
AJCC IIB 21 7 1
  IIIA 25 11 1
  IIIB 12 2 -
  IV 2 3 -
ER status + 41 7 2
  - 19 15 -
  unknown - 1 -
PgR status + 32 14 2
  - 28 18 -
  unknown - 1 -
Nodes + 32 14 1
  - 28 9 1
Metastasis + 2 2 0
  - 58 21 2
  1. *NA, not applicable--One patient without following up and one patient dead by other causes; AJCC, American Joint Committee on Cancer; Both1, sequential treatment with Epirubicin and Paclitaxel